Evidence map›Paper›PMID 35723106›Full record

ArticleJournal of Alzheimer's disease : JAD2022

Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.

Avram S Bukhbinder, Yaobin Ling, Omar Hasan, Xiaoqian Jiang, Yejin Kim, Kamal N Phelps, Rosemarie E Schmandt, Albert Amran, Ryan Coburn, Srivathsan Ramesh and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 4 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 4 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Modeling the Exposome in Murine Cardiovascular Disease.JACC. Basic to translational science · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Global vaccine development.Nature medicine · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Association between shingles vaccination and slower biological aging: evidence from a US population-based cohort study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  16. Review
  17. Exploring the role of infectious pathogens in Alzheimer's disease neuroinflammation.Frontiers in cellular and infection microbiology · 2026
    Review
  18. Review
  19. Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Avram S BukhbinderJohn P. and Katherine G. McGovern Medical School at UTHealth, Houston, TX, USA.
Yaobin LingUTHealth School of Biomedical Informatics, Houston, TX, USA.
Omar Hasan
Xiaoqian JiangUTHealth School of Biomedical Informatics, Houston, TX, USA.
Yejin KimUTHealth School of Biomedical Informatics, Houston, TX, USA.
Kamal N PhelpsJohn P. and Katherine G. McGovern Medical School at UTHealth, Houston, TX, USA.
Rosemarie E SchmandtJohn P. and Katherine G. McGovern Medical School at UTHealth, Houston, TX, USA.
Albert AmranJohn P. and Katherine G. McGovern Medical School at UTHealth, Houston, TX, USA.
Ryan CoburnJohn P. and Katherine G. McGovern Medical School at UTHealth, Houston, TX, USA.
Srivathsan RameshJohn P. and Katherine G. McGovern Medical School at UTHealth, Houston, TX, USA.
Qian XiaoUTHealth School of Public Health, Houston, TX, USA.
Paul E SchulzJohn P. and Katherine G. McGovern Medical School at UTHealth, Houston, TX, USA.
The University of Texas Health Science Center at Houston · USBukhara State University · UZUniversity of Texas Health Science Center at Dallas · US

Funding

Open Health Natural Language Processing CollaboratoryU01TR002062 · NCATS · MAYO CLINIC ROCHESTER · PI JIANG, XIAOQIAN, LIU, HONGFANG · 2017 to 2021
$7.6M
SHARE: Statistical Health Information Release with Differential PrivacyR01GM114612 · NIGMS · EMORY UNIVERSITY · PI XIONG, LI · 2015 to 2017
$1.0M
NCATS NIH HHS U01 TR002062NIGMS NIH HHS R01 GM114612
6 · The paper itself

Abstract

backgroundPrior studies have found a reduced risk of dementia of any etiology following influenza vaccination in selected populations, including veterans and patients with serious chronic health conditions. However, the effect of influenza vaccination on Alzheimer's disease (AD) risk in a general cohort of older US adults has not been characterized.

objectiveTo compare the risk of incident AD between patients with and without prior influenza vaccination in a large US claims database.

methodsDeidentified claims data spanning September 1, 2009 through August 31, 2019 were used. Eligible patients were free of dementia during the 6-year look-back period and≥65 years old by the start of follow-up. Propensity-score matching (PSM) was used to create flu-vaccinated and flu-unvaccinated cohorts with similar baseline demographics, medication usage, and comorbidities. Relative risk (RR) and absolute risk reduction (ARR) were estimated to assess the effect of influenza vaccination on AD risk during the 4-year follow-up.

resultsFrom the unmatched sample of eligible patients (n = 2,356,479), PSM produced a sample of 935,887 flu-vaccinated-unvaccinated matched pairs. The matched sample was 73.7 (SD, 8.7) years of age and 56.9% female, with median follow-up of 46 (IQR, 29-48) months; 5.1% (n = 47,889) of the flu-vaccinated patients and 8.5% (n = 79,630) of the flu-unvaccinated patients developed AD during follow-up. The RR was 0.60 (95% CI, 0.59-0.61) and ARR was 0.034 (95% CI, 0.033-0.035), corresponding to a number needed to treat of 29.4.

conclusionThis study demonstrates that influenza vaccination is associated with reduced AD risk in a nationwide sample of US adults aged 65 and older.

Indexed as

Alzheimer DiseaseInfluenza, HumanAdultAgedChronic DiseaseCohort StudiesFemaleHumansMaleMiddle AgedPropensity ScoreVaccinationAlzheimer’s diseasecohort studiesincidenceinfluenza vaccinespharmacoepidemiologyretrospective studiesvaccination

Identifiers

PMID35723106
PMCPMC9484126
OpenAlexW4282842995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.